BioCentury | Jul 17, 2020
Finance

July 16 Quick Takes: Biotech stocks fare worse than others in STAR tumble; plus BioAtla, Exalys, Virometix, Biose, Spirea

...fared worse than the Shanghai Composite Index’s 4.5% downturn on Thursday. Bio-Thera Solutions Ltd. (Shanghai:688177), Shenzhen Chipscreen...
BioCentury | Dec 2, 2019
Company News

Dec. 2 Regulatory Roundup: Chipscreen’s approval; plus Priority Review for new Imfinzi, Keytruda indications; EMA reviewing Orchard, Amarin candidates; and more

...breast cancer in hormone receptor-positive, HER2-negative, postmenopausal patients who relapsed or progressed after endocrine therapy. Shenzhen Chipscreen Biosciences Ltd....
...miraxion, AMR-101, LAX-101) luspatercept (ACE-536) tazemetostat (E7438, EPZ-6438) Lynparza, olaparib (AZD2281, KU-0059436, MK-7339) Zynquista, sotagliflozin (SAR439954, lx4211 tablet) [MERGED] AstraZeneca plc Shenzhen Chipscreen...
BioCentury | Nov 16, 2019
Finance

Shanghai’s STAR rises as a destination for biotech IPOs

...July, and so far, two Chinese therapeutics developers have had their initial listing on STAR: Shenzhen Chipscreen...
BioCentury | Oct 4, 2019
Finance

Biotech down again in 3Q19

...Response to CMC Issues" ). The biggest gain in the $1-$4.9 billion group came from Shenzhen Chipscreen Biosciences Ltd....
...Protein kinase C epsilon Meredith Durkin Wolfe, Associate Editor, Data & Analytics Sarepta Therapeutics Inc. Genmab A/S Galapagos N.V. Nektar Therapeutics Shenzhen Chipscreen...
BioCentury | Oct 4, 2019
Finance

Biotechs likely to flood IPO market ahead of 2020 election

...Inc. (NASDAQ:SWTX) 09/12/19 $186.3 $778.2 $937.3 20% StemRIM Inc. (Tokyo:4599) 08/09/19 $75.7 $493.9 $459.5 -7% Shenzhen Chipscreen Biosciences Ltd....
BioCentury | Sep 4, 2019
Financial News

Sept. 4 Financial Quick Takes: BrightGene looks to STAR; plus IPO updates from Immunotech, 10x Genomics, SpringWorks, IGM, Satsuma and more

...cancer and viral infections and manufactures APIs. Last month, the first biopharma on the market, Shenzhen Chipscreen Biosciences Ltd....
BioCentury | Aug 14, 2019
Financial News

Aug. 14 Financial Quick Takes: Biotech tumbles with markets; plus Frontier, Portola and more

...albuvirtide, a long-acting viral entry inhibitor targeting HIV gp41. The first biotech on the exchange, Shenzhen Chipscreen Biosciences Ltd....
BioCentury | Aug 12, 2019
Finance

Chipscreen sets high standard in Shanghai debut

...on the sidelines to choose a mainland listing over one in Hong Kong. Shares of Shenzhen Chipscreen Biosciences Ltd....
...months from the suspension date to report updated financial statements. Hongjiang Li, Staff Writer Epidaza, chidamide (CS055, HBI-8000) Shenzhen Chipscreen...
BioCentury | Jul 31, 2019
Financial News

Chipscreen sets pace for biotech IPOs in Shanghai

...gains for the first companies to list will likely extend to biotechs in the queue. Shenzhen Chipscreen Biosciences Ltd....
...Biotech Co. Ltd. (Xiamen, China), and Shanghai Serum Bio-Technology Co. Ltd (Shanghai, China). Hongjiang Li, Staff Writer Shenzhen Chipscreen...
BioCentury | Jul 22, 2019
Financial News

July 22 Financial Quick Takes: Shanghai's rising STAR; plus Retrotrope and RAPT

...trading Monday. The first biotech to debut on the STAR market is expected to be Shenzhen Chipscreen Biosciences Ltd....
..."On Heels of Series C Extension, RAPT Therapeutics Files for IPO" ). Hongjiang Li, Staff Writer Retrotope Inc. Shenzhen Chipscreen...
Items per page:
1 - 10 of 26
BioCentury | Jul 17, 2020
Finance

July 16 Quick Takes: Biotech stocks fare worse than others in STAR tumble; plus BioAtla, Exalys, Virometix, Biose, Spirea

...fared worse than the Shanghai Composite Index’s 4.5% downturn on Thursday. Bio-Thera Solutions Ltd. (Shanghai:688177), Shenzhen Chipscreen...
BioCentury | Dec 2, 2019
Company News

Dec. 2 Regulatory Roundup: Chipscreen’s approval; plus Priority Review for new Imfinzi, Keytruda indications; EMA reviewing Orchard, Amarin candidates; and more

...breast cancer in hormone receptor-positive, HER2-negative, postmenopausal patients who relapsed or progressed after endocrine therapy. Shenzhen Chipscreen Biosciences Ltd....
...miraxion, AMR-101, LAX-101) luspatercept (ACE-536) tazemetostat (E7438, EPZ-6438) Lynparza, olaparib (AZD2281, KU-0059436, MK-7339) Zynquista, sotagliflozin (SAR439954, lx4211 tablet) [MERGED] AstraZeneca plc Shenzhen Chipscreen...
BioCentury | Nov 16, 2019
Finance

Shanghai’s STAR rises as a destination for biotech IPOs

...July, and so far, two Chinese therapeutics developers have had their initial listing on STAR: Shenzhen Chipscreen...
BioCentury | Oct 4, 2019
Finance

Biotech down again in 3Q19

...Response to CMC Issues" ). The biggest gain in the $1-$4.9 billion group came from Shenzhen Chipscreen Biosciences Ltd....
...Protein kinase C epsilon Meredith Durkin Wolfe, Associate Editor, Data & Analytics Sarepta Therapeutics Inc. Genmab A/S Galapagos N.V. Nektar Therapeutics Shenzhen Chipscreen...
BioCentury | Oct 4, 2019
Finance

Biotechs likely to flood IPO market ahead of 2020 election

...Inc. (NASDAQ:SWTX) 09/12/19 $186.3 $778.2 $937.3 20% StemRIM Inc. (Tokyo:4599) 08/09/19 $75.7 $493.9 $459.5 -7% Shenzhen Chipscreen Biosciences Ltd....
BioCentury | Sep 4, 2019
Financial News

Sept. 4 Financial Quick Takes: BrightGene looks to STAR; plus IPO updates from Immunotech, 10x Genomics, SpringWorks, IGM, Satsuma and more

...cancer and viral infections and manufactures APIs. Last month, the first biopharma on the market, Shenzhen Chipscreen Biosciences Ltd....
BioCentury | Aug 14, 2019
Financial News

Aug. 14 Financial Quick Takes: Biotech tumbles with markets; plus Frontier, Portola and more

...albuvirtide, a long-acting viral entry inhibitor targeting HIV gp41. The first biotech on the exchange, Shenzhen Chipscreen Biosciences Ltd....
BioCentury | Aug 12, 2019
Finance

Chipscreen sets high standard in Shanghai debut

...on the sidelines to choose a mainland listing over one in Hong Kong. Shares of Shenzhen Chipscreen Biosciences Ltd....
...months from the suspension date to report updated financial statements. Hongjiang Li, Staff Writer Epidaza, chidamide (CS055, HBI-8000) Shenzhen Chipscreen...
BioCentury | Jul 31, 2019
Financial News

Chipscreen sets pace for biotech IPOs in Shanghai

...gains for the first companies to list will likely extend to biotechs in the queue. Shenzhen Chipscreen Biosciences Ltd....
...Biotech Co. Ltd. (Xiamen, China), and Shanghai Serum Bio-Technology Co. Ltd (Shanghai, China). Hongjiang Li, Staff Writer Shenzhen Chipscreen...
BioCentury | Jul 22, 2019
Financial News

July 22 Financial Quick Takes: Shanghai's rising STAR; plus Retrotrope and RAPT

...trading Monday. The first biotech to debut on the STAR market is expected to be Shenzhen Chipscreen Biosciences Ltd....
..."On Heels of Series C Extension, RAPT Therapeutics Files for IPO" ). Hongjiang Li, Staff Writer Retrotope Inc. Shenzhen Chipscreen...
Items per page:
1 - 10 of 26